| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.1M | -13.3% | -32.1% |
| Cost of Revenue | $15.3M | -15.3% | -33.0% |
| Gross Profit | $11.8M | -10.5% | -31.0% |
| R&D Expense | $10.1M | -11.4% | +79.7% |
| SG&A Expense | $11.1M | -12.6% | +12.7% |
| Operating Income | -$16.1M | +10.7% | -168.2% |
| Pre-tax Income | -$13.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $216.5M | -7.7% | -22.3% |
| Accounts Receivable | $24.3M | -6.2% | -9.8% |
| Inventory | $33.4M | +0.1% | -14.1% |
| Current Assets | $283.0M | -6.1% | -19.2% |
| Total Assets | $423.1M | -4.9% | -8.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.0M | — | — |
| Capital Expenditures | $3.3M | — | — |
| Investing Cash Flow | -$2.4M | — | — |
| Financing Cash Flow | -$11.8M | — | — |
| Free Cash Flow | -$43.3M | — | — |
| +21.3% |
| -313.0% |
| Income Tax | $47K | -97.7% | -93.1% |
| Net Income | -$13.7M | +30.4% | -204.2% |
| EPS (Basic) | -$0.19 | +26.9% | -216.7% |
| EPS (Diluted) | -$0.19 | +26.9% | -216.7% |
| $40.2M |
| -5.0% |
| +44.9% |
| Total Liabilities | $61.1M | -5.0% | +58.7% |
| Stockholders' Equity | $362.0M | -4.9% | -14.9% |